Charles Schwab’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Buy |
303,887
+16,171
| +6% | +$178K | ﹤0.01% | 2497 |
|
|
2025
Q1 | $2.57M | Sell |
287,716
-6,220
| -2% | -$55.5K | ﹤0.01% | 2532 |
|
|
2024
Q4 | $2.77M | Buy |
293,936
+2,060
| +0.7% | +$19.4K | ﹤0.01% | 2577 |
|
|
2024
Q3 | $2.35M | Buy |
291,876
+610
| +0.2% | +$4.92K | ﹤0.01% | 2658 |
|
|
2024
Q2 | $2.47M | Sell |
291,266
-19,235
| -6% | -$163K | ﹤0.01% | 2630 |
|
|
2024
Q1 | $2.79M | Sell |
310,501
-3,510
| -1% | -$31.5K | ﹤0.01% | 2502 |
|
|
2023
Q4 | $3.53M | Sell |
314,011
-14,166
| -4% | -$159K | ﹤0.01% | 2455 |
|
|
2023
Q3 | $2.83M | Sell |
328,177
-75,282
| -19% | -$650K | ﹤0.01% | 2492 |
|
|
2023
Q2 | $4.18M | Sell |
403,459
-79,413
| -16% | -$822K | ﹤0.01% | 2304 |
|
|
2023
Q1 | $5.24M | Sell |
482,872
-33,516
| -6% | -$364K | ﹤0.01% | 2182 |
|
|
2022
Q4 | $5.79M | Sell |
516,388
-8,528
| -2% | -$95.7K | ﹤0.01% | 2142 |
|
|
2022
Q3 | $5.32M | Buy |
524,916
+21,439
| +4% | +$217K | ﹤0.01% | 2187 |
|
|
2022
Q2 | $4.56M | Buy |
503,477
+100,837
| +25% | +$914K | ﹤0.01% | 2222 |
|
|
2022
Q1 | $3.85M | Buy |
402,640
+12,095
| +3% | +$116K | ﹤0.01% | 2397 |
|
|
2021
Q4 | $4.32M | Buy |
390,545
+38,752
| +11% | +$428K | ﹤0.01% | 2422 |
|
|
2021
Q3 | $2.6M | Sell |
351,793
-4,751
| -1% | -$35.2K | ﹤0.01% | 2636 |
|
|
2021
Q2 | $5.18M | Buy |
356,544
+23,060
| +7% | +$335K | ﹤0.01% | 2335 |
|
|
2021
Q1 | $6.81M | Buy |
333,484
+9,906
| +3% | +$202K | ﹤0.01% | 2148 |
|
|
2020
Q4 | $5.75M | Buy |
323,578
+10,014
| +3% | +$178K | ﹤0.01% | 2147 |
|
|
2020
Q3 | $4.64M | Sell |
313,564
-646
| -0.2% | -$9.55K | ﹤0.01% | 2095 |
|
|
2020
Q2 | $6.6M | Buy |
314,210
+14,634
| +5% | +$307K | ﹤0.01% | 1894 |
|
|
2020
Q1 | $6.92M | Buy |
299,576
+31,476
| +12% | +$727K | ﹤0.01% | 1660 |
|
|
2019
Q4 | $6.94M | Buy |
268,100
+9,237
| +4% | +$239K | ﹤0.01% | 1849 |
|
|
2019
Q3 | $5.04M | Buy |
258,863
+6,869
| +3% | +$134K | ﹤0.01% | 1954 |
|
|
2019
Q2 | $4.12M | Buy |
251,994
+13,042
| +5% | +$213K | ﹤0.01% | 2067 |
|
|
2019
Q1 | $5.42M | Buy |
238,952
+4,070
| +2% | +$92.3K | ﹤0.01% | 1948 |
|
|
2018
Q4 | $6.01M | Sell |
234,882
-1,978
| -0.8% | -$50.6K | ﹤0.01% | 1800 |
|
|
2018
Q3 | $7.74M | Buy |
236,860
+10,592
| +5% | +$346K | 0.01% | 1795 |
|
|
2018
Q2 | $5.13M | Buy |
226,268
+17,193
| +8% | +$390K | ﹤0.01% | 1985 |
|
|
2018
Q1 | $5.07M | Buy |
209,075
+9,398
| +5% | +$228K | ﹤0.01% | 1934 |
|
|
2017
Q4 | $5.57M | Buy |
199,677
+8,119
| +4% | +$226K | ﹤0.01% | 1878 |
|
|
2017
Q3 | $6.56M | Buy |
191,558
+14,241
| +8% | +$488K | 0.01% | 1734 |
|
|
2017
Q2 | $7.07M | Buy |
177,317
+14,709
| +9% | +$586K | 0.01% | 1595 |
|
|
2017
Q1 | $5.99M | Buy |
162,608
+17,136
| +12% | +$631K | 0.01% | 1651 |
|
|
2016
Q4 | $4.64M | Buy |
145,472
+26,088
| +22% | +$832K | 0.01% | 1787 |
|
|
2016
Q3 | $4.33M | Buy |
119,384
+5,734
| +5% | +$208K | 0.01% | 1740 |
|
|
2016
Q2 | $2.58M | Buy |
113,650
+29,512
| +35% | +$670K | ﹤0.01% | 1938 |
|
|
2016
Q1 | $1.58M | Sell |
84,138
-5,136
| -6% | -$96.6K | ﹤0.01% | 2166 |
|
|
2015
Q4 | $1.46M | Buy |
89,274
+15,258
| +21% | +$250K | ﹤0.01% | 2222 |
|
|
2015
Q3 | $814K | Buy |
74,016
+4,823
| +7% | +$53K | ﹤0.01% | 2450 |
|
|
2015
Q2 | $901K | Buy |
69,193
+2,152
| +3% | +$28K | ﹤0.01% | 2456 |
|
|
2015
Q1 | $1.16M | Buy |
67,041
+3,162
| +5% | +$54.9K | ﹤0.01% | 2317 |
|
|
2014
Q4 | $954K | Buy |
63,879
+2,133
| +3% | +$31.9K | ﹤0.01% | 2365 |
|
|
2014
Q3 | $1.42M | Buy |
61,746
+1,361
| +2% | +$31.4K | ﹤0.01% | 2142 |
|
|
2014
Q2 | $1.93M | Buy |
+60,385
| New | +$1.93M | ﹤0.01% | 2004 |
|